Jiangsu Hualan Stock Hits Day Low of CNY 109.69 Amid Price Pressure

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. experienced a notable decline today, with the stock dropping by 5.79% and reaching an intraday low of CNY 109.69. This performance contrasts sharply with the China Shanghai Composite, which fell by 2.04% on the same day. Despite a strong year-to-date performance of 115.68% and a remarkable annual increase of 291.23%, the company has faced significant challenges. Over the past five years, net sales have decreased at an annual rate of 2.11%, while operating profit has plummeted by 37.25%. The company has reported negative results for seven consecutive quarters, with a recent 11% drop in net sales. Financial metrics indicate a low return on capital employed (ROCE) of 9.64%, reflecting limited profitability relative to total capital. Additionally, the company’s return on equity (ROE) stands at a modest 1.90%, and it has a high price-to-book ratio of 7.30. These factors contribute to a complex financial landscape for Jiangsu Hualan, as it navigates current market conditions.